The goal of the Structural Biology Program (Program 5) is to bring a wide range of structural approaches to bear on the proteins involved in carcinogenesis, use this structural information to gain hovel insights into function, and to translate this understanding into novel therapeutic strategies. Detailed understanding of molecular function in biological systems requires information about the 3D structures of macromolecules. This information can range from very high-resolution structural information derived from x-ray or NMR studies to lower resolution structural information from electron microscopy or atomic force microscopy. In all cases, however, the wealth of information available from structural studies of macromolecules using these approaches provides novel and powerful insights into function. Such information is critical for understanding the functions of proteins involved in carcinogenesis as it provides a meaningful framework to design experiments to test function, for example by highly selective mutagenesis. Structures give a basis for understanding the alteration in function that accompany naturally occurring mutations in cancer, either in oncogenes or tumor suppressor proteins. In addition, structural studies by such biophysical methods provide the basis for initiating programs of targeted drug design that are clearly the paradigm for future development of targeted cancer therapeutics. The Program is comprised of 15 investigators from five Departments, four from the School of Medicine and one (Department of Chemistry) from the College of Arts and Sciences. This group of investigators has $8.8M in yearly direct costs from peer-reviewed research funding, including $390K from NCI. Members of the Program have played prominent roles in the structural genomics efforts underway here in the US. In addition, three faculty members are the Pis on large multi-investigator multi-institution grants. During the last grant period, the Program in Structural Biology has generated a total of 230 publications with 27% intra-programmatic publications and 12% inter-programmatic publications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA044579-18
Application #
7726775
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
18
Fiscal Year
2008
Total Cost
$7,640
Indirect Cost
Name
University of Virginia
Department
Type
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Cruickshanks, Nichola; Zhang, Ying; Hine, Sarah et al. (2018) Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in Glioblastoma. Clin Cancer Res :
Balogh, Kristen N; Templeton, Dennis J; Cross, Janet V (2018) Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses. PLoS One 13:e0197702
Gonzalez, Phillippe P; Kim, Jungeun; Galvao, Rui Pedro et al. (2018) p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression. Glia 66:999-1015
Rodriguez, Anthony B; Peske, J David; Engelhard, Victor H (2018) Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma. Methods Mol Biol 1845:241-257
Stowman, Anne M; Hickman, Alexandra W; Mauldin, Ileana S et al. (2018) Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures. Melanoma Res 28:237-245
Melhuish, Tiffany A; Kowalczyk, Izabela; Manukyan, Arkadi et al. (2018) Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression. Biochim Biophys Acta Gene Regul Mech 1861:983-995
Kulling, Paige M; Olson, Kristine C; Olson, Thomas L et al. (2018) Calcitriol-mediated reduction in IFN-? output in T cell large granular lymphocytic leukemia requires vitamin D receptor upregulation. J Steroid Biochem Mol Biol 177:140-148
Carlton, Anne L; Illendula, Anuradha; Gao, Yan et al. (2018) Small molecule inhibition of the CBF?/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transition. Gynecol Oncol 149:350-360
Borten, Michael A; Bajikar, Sameer S; Sasaki, Nobuo et al. (2018) Automated brightfield morphometry of 3D organoid populations by OrganoSeg. Sci Rep 8:5319
Olson, Kristine C; Kulling Larkin, Paige M; Signorelli, Rossana et al. (2018) Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes. Cytokine 111:551-562

Showing the most recent 10 out of 539 publications